Home | Working Groups publications

Working Groups publications

10 / 103 risultati trovati

Clinical Management of Peripheral Arterial Disease in Chronic Kidney Disease – a comprehensive review from the European Renal Association CKD-MBD Working Group

Aprile 07, 2025

CKD-MBD WG

Very low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events

Marzo 07, 2025

EuReCa-M WG

Kidney expert consultation and the outcomes of in hospital acute kidney injury

Febbraio 28, 2025

ERAKI WG

Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K working group of the ERA, and ESPN

Febbraio 21, 2025

G&K WG

The impact of the new WHO Classification of renal cell carcinoma on the diagnosis of hereditary leiomyomatosis and renal cell carcinoma

Febbraio 20, 2025

G&K WG

Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)

Febbraio 08, 2025

IWG WG

Haemodiafiltration versus high-flux haemodialysis – a Consensus Statement from the EuDial Working Group of the ERA

Febbraio 06, 2025

EuDial WG

The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation – a European consensus statement

Gennaio 28, 2025

CKD-MBD WG

Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A consensus statement of the ERA Genes & Kidney Working Group

Gennaio 23, 2025

G&K WG

DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction – Implications for clinicians

Gennaio 15, 2025

ERAKI WG

Mostra di più

Unisciti ai Working Group di ERA o rinnova il tuo interesse

Scopri le storie dei nostri membri

La malattia renale nell'agenda della sanità pubblica Webinar

Le candidature per le borse ERA sono ora aperte

Accedi a ERA e-learning

Prova gli gnocchi "sordi":

Webcast disponibile!

Webcast disponibile!

Suggestions

Working Groups publications

{%TITLE%}

{%TITLE%}

Clinical Management of Peripheral Arterial Disease in Chronic Kidney Disease – a comprehensive review from the European Renal Association CKD-MBD Working Group

Very low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events

Kidney expert consultation and the outcomes of in hospital acute kidney injury

Global access to management of primary hyperoxaluria: a survey on behalf of OxalEurope, G&K working group of the ERA, and ESPN

The impact of the new WHO Classification of renal cell carcinoma on the diagnosis of hereditary leiomyomatosis and renal cell carcinoma

Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)

Haemodiafiltration versus high-flux haemodialysis – a Consensus Statement from the EuDial Working Group of the ERA

The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation – a European consensus statement

Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A consensus statement of the ERA Genes & Kidney Working Group

DEFENDER Trial: Dapagliflozin for Critically Ill Patients with Acute Organ Dysfunction – Implications for clinicians